Baxter announces cash tender offers for $500 million
The offers target four series of senior notes, with early tender premium of $30 per $1,000 principal and expiration on Sept. 1, 2026.
See the latest news and media coverage for Baxter. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of medical devices, clinical nutrition, and connected-care solutions
baxter.comLast updated
In short: Baxter International reported strong Q2 2026 earnings and raised its annual forecast while navigating product recalls and divestitures.
The offers target four series of senior notes, with early tender premium of $30 per $1,000 principal and expiration on Sept. 1, 2026.
Second-quarter sales rose 5% to $2.96 billion, adjusted EPS was $0.56, and the company raised its full-year outlook.
The call is on July 30, 2026 at 7:30 a.m. Central Time and can be accessed via webcast.
The report includes new net-zero and renewable electricity targets, and a new chief sustainability officer role.
Cyber attacks continue to affect medtech companies. This time, it is Baxter that has been subjected to an intrusion.
Baxter International (BAX) is back in focus after its latest earnings report showed higher quarterly sales and net income compared with last year, along with...
Baxter administration sets may have air bubbles in the drip chamber and tubing, which may result in air being delivered through the IV line to...
July 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to...
Track Baxter and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.